Sundar S - Search Results

1

A systematic review evaluating the relationship between progression free survival and post progression survival in advanced ovarian cancer.

Sundar S, Wu J, Hillaby K, Yap J, Lilford R. Sundar S, et al. Gynecol Oncol. 2012 May;125(2):493-9. doi: 10.1016/j.ygyno.2011.12.420. Epub 2011 Dec 8. Gynecol Oncol. 2012. PMID: 22155676 Review.

2

Cervical cancer.

Sundar S, Horne A, Kehoe S. Sundar S, et al. BMJ Clin Evid. 2008 Mar 14;2008:0818. BMJ Clin Evid. 2008. PMID: 19450324 Review.

3

Should grade 3 endometrioid endometrial carcinoma be considered a type 2 cancer-a clinical and pathological evaluation.

Voss MA, Ganesan R, Ludeman L, McCarthy K, Gornall R, Schaller G, Wei W, Sundar S. Voss MA, et al. Among authors: sundar s. Gynecol Oncol. 2012 Jan;124(1):15-20. doi: 10.1016/j.ygyno.2011.07.030. Epub 2011 Aug 23. Gynecol Oncol. 2012. PMID: 21864888

4

Evaluating PET-CT in routine surveillance and follow-up after treatment for cervical cancer: a cost-effectiveness analysis.

Auguste P, Barton P, Meads C, Davenport C, Małysiak S, Kowalska M, Zapalska A, Guest P, Martin-Hirsch P, Borowiack E, Khan K, Sundar S, Roberts T. Auguste P, et al. Among authors: sundar s. BJOG. 2014 Mar;121(4):464-76. doi: 10.1111/1471-0528.12460. Epub 2013 Dec 3. BJOG. 2014. PMID: 24299112

5

Patient-Reported Outcomes After Extensive (Ultraradical) Surgery for Ovarian Cancer: Results From a Prospective Longitudinal Feasibility Study.

Soo Hoo S, Marriott N, Houlton A, Nevin J, Balega J, Singh K, Yap J, Sethuram R, Elattar A, Luesley D, Kehoe S, Sundar S. Soo Hoo S, et al. Among authors: sundar s. Int J Gynecol Cancer. 2015 Nov;25(9):1599-607. doi: 10.1097/IGC.0000000000000551. Int J Gynecol Cancer. 2015. PMID: 26397157

6

Methods Used in Economic Evaluations of Testing and Diagnosis for Ovarian Cancer: A Systematic Review.

Sharma V, Sundar SS, Breheny K, Monahan M, Sutton AJ. Sharma V, et al. Among authors: sundar ss. Int J Gynecol Cancer. 2016 Jun;26(5):865-72. doi: 10.1097/IGC.0000000000000699. Int J Gynecol Cancer. 2016. PMID: 27051058 Free article. Review.

7

Reporting 'Denominator' data is essential for benchmarking and quality standards in ovarian cancer.

Phillips A, Balega J, Nevin J, Singh K, Elattar A, Kehoe S, Sundar S. Phillips A, et al. Among authors: sundar s. Gynecol Oncol. 2017 Jul;146(1):94-100. doi: 10.1016/j.ygyno.2017.04.007. Epub 2017 Apr 12. Gynecol Oncol. 2017. PMID: 28411948 Free article.

8

Predictive value of the age-adjusted Charlston co-morbidity index on peri-operative complications, adjuvant chemotherapy usage and survival in patients undergoing debulking surgery after neo-adjuvant chemotherapy for advanced epithelial ovarian cancer.

Phillips A, Singh K, Pounds R, Sundar S, Kehoe S, Nevin J, Elattar A, Balega J. Phillips A, et al. Among authors: sundar s. J Obstet Gynaecol. 2017 Nov;37(8):1070-1075. doi: 10.1080/01443615.2017.1324413. Epub 2017 Jul 25. J Obstet Gynaecol. 2017. PMID: 28741395

9

Complete cytoreduction after five or more cycles of neo-adjuvant chemotherapy confers a survival benefit in advanced ovarian cancer.

Phillips A, Sundar S, Singh K, Nevin J, Elattar A, Kehoe S, Balega J. Phillips A, et al. Among authors: sundar s. Eur J Surg Oncol. 2018 Jun;44(6):760-765. doi: 10.1016/j.ejso.2018.01.097. Epub 2018 Jan 31. Eur J Surg Oncol. 2018. PMID: 29426779 Free article.

10

Quality of life outcomes following surgery for advanced ovarian cancer: a systematic review and meta-analysis.

Kumar S, Long J, Kehoe S, Sundar S, Cummins C. Kumar S, et al. Among authors: sundar s. Int J Gynecol Cancer. 2019 Oct;29(8):1285-1291. doi: 10.1136/ijgc-2018-000125. Epub 2019 Jul 3. Int J Gynecol Cancer. 2019. PMID: 31273066

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,133 results

Search Page